Ningetinib (CT-053) is a potent, orally active small molecule inhibitor targeting Axl, VEGFR2, and c-Met kinases with low nanomolar IC50 values. It is utilized in preclinical cancer research, particularly in studies investigating tumor angiogenesis, metastasis, and resistance mechanisms in both cellular and animal models.
Molecular Weight:
556.58
Purity:
99.98% (May vary between batches)
CAS Number:
[1394820-69-9]
Formula:
C31H29FN4O5
Target:
VEGFR,TAM Receptor,c-Met/HGFR
Application Notes:
Solubility: DMSO:15 mg/mL (26.95 mM)
* VAT and and shipping costs not included. Errors and price changes excepted